在肝移植中等待时间的好处和危害 对于HCC的肝移植
Pam Elisabeth van der Meeren1, Roeland Frederik de Wilde1, Dave Sprengers2
1Department of Surgery, Division of HPB & Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Hepatology (Baltimore, Md.)
|November 16, 2023
概括
肝移植等待时间 (LT) 对肝癌 (HCC) 患者的结果有显著影响. 优化器官的可用性和选择标准对于成功治疗HCC和减少移植延迟至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 在瘤学瘤学.
背景情况:
- 肝移植是有限阶段肝细胞癌 (HCC) 的首要治疗方法.
- 肝移植等待时间 (LT) 极大地影响HCC患者的预后.
- 随着对捐献器官的需求不断增加,需要改进等候名单管理和器官的可用性.
研究的目的:
- 审查等待时间持续时间对等待LT的HCC患者结果的影响.
- 讨论优化等待时间和器官利用的策略,在LT中针对HCC.
- 探索LT不断变化的选择标准,包括瘤生物学和生物标志物.
主要方法:
- 文献综述侧重于研究LT等待时间和HCC结果的研究.
- 对扩大捐赠者池 (活体捐赠者,扩展标准捐赠者) 的当前创新进行分析.
- 讨论对LT的HCC患者选择的进展,包括基于分子和生物标志物的标准.
主要成果:
- 等待时间是HCC患者等待LT的瘤预后的关键决定因素.
- 像活体捐献者LT和扩展标准捐献者这样的创新旨在增加器官的可用性.
- 不断发展的选择标准平衡了移植资格与防止徒劳的程序.
结论:
- 优化等待时间和器官分配对于最大限度地提高HCC中LT益处至关重要.
- 通过了解瘤生物学和分子遗传学,个性化的HCC治疗方法正在进步.
- 精细的选择标准,包括生物标志物,对于在不断增长的HCC患者群体中有效的LT至关重要.
相关概念视频
01:28Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
01:26Kidney Transplant II: Surgical Procedure
20
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
20